Carl Zeiss Meditec AG (FRA:AFXA)

Market Cap	3.61B
Revenue (ttm)	2.23B
Net Income (ttm)	141.21M
Shares Out	n/a
EPS (ttm)	1.61
PE Ratio	25.58
Forward PE	20.62
Dividend	0.38 (0.95%)
Ex-Dividend Date	Mar 28, 2025

Volume	n/a
Average Volume	27
Open	41.00
Previous Close	42.40
Day's Range	41.00 - 41.00
52-Week Range	38.60 - 70.00
Beta	n/a
RSI	50.17
Earnings Date	Feb 12, 2026

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and p...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1846
• Employees: 5,784
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AFXA

Financial Performance

In 2025, Carl Zeiss Meditec AG's revenue was 2.23 billion, an increase of 7.82% compared to the previous year's 2.07 billion. Earnings were 141.21 million, a decrease of -20.99%.